Ongoing research has revealed that the existence of cancer stem cells (CSCs) is one of the
biggest obstacles in the current cancer therapy. CSCs make an influential function in tumor …

The development and immune evasion of cancer stem cells (CSCs) limit the efficacy of
currently available anticancer therapies. Recent studies have shown that epigenetic …

Cancer stem cells (CSCs) have emerged as key contributors to tumor initiation, growth, and
metastasis. In addition, CSCs play a significant role in inducing immune evasion, thereby …

Cancer stem cells (CSCs) are subpopulations of undifferentiated cancer cells within the
tumor bulk that are responsible for tumor initiation, recurrence and therapeutic resistance …

The primary reason for high mortality rates among cancer patients is metastasis, where
tumor cells migrate through the bloodstream from the original site to other parts of the body …

Exploration of tumor immunity leads to the development of immune checkpoint inhibitors and
cell-based immunotherapies which improve the clinical outcomes in several tumor types …

Cross talk between cancer cells and the immune system is determinant for cancer
progression. Emerging evidence demonstrates that GC characteristics such as metastasis …

Obesity is a major driving factor in the incidence, progression, and poor treatment response
in gastrointestinal cancers. Herein, we conducted a comprehensive analysis of the impact of …

Abstract Background Regulatory T (Treg) cells are important components of the tumour
microenvironment (TME) that play roles in gastric cancer (GC) metastasis. Although tumour …

In populations with similar prevalence of Helicobacter pylori infection, cancer risk can vary
dramatically. Changes in composition or structure of bacterial communities in the stomach …